Related references
Note: Only part of the references are listed.Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
Harald Hugenschmidt et al.
ANNALS OF SURGERY (2020)
Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
Lei Huang et al.
GUT (2019)
Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors
Isabel Romero-Calvo et al.
MOLECULAR CANCER RESEARCH (2019)
Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry
Salvatore Paiella et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Vincent Bernard et al.
GASTROENTEROLOGY (2019)
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
Susan Tsai et al.
BMC CANCER (2018)
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
E. Versteijne et al.
BRITISH JOURNAL OF SURGERY (2018)
Patient-derived organoid models help define personalized management of gastrointestinal cancer
M. R. Aberle et al.
BRITISH JOURNAL OF SURGERY (2018)
Defining the molecular pathology of pancreatic body and tail adenocarcinoma
S. B. Dreyer et al.
BRITISH JOURNAL OF SURGERY (2018)
Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer
O. Nordgard et al.
BRITISH JOURNAL OF SURGERY (2018)
Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer
S. R. Markar et al.
BRITISH JOURNAL OF SURGERY (2018)
Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance
Martin Wartenberg et al.
CLINICAL CANCER RESEARCH (2018)
Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Katharina E. Effenberger et al.
CLINICAL CANCER RESEARCH (2018)
Intraductal Papillary Mucinous Neoplasm as the Focus for Early Detection of Pancreatic Cancer
Masao Tanaka
GASTROENTEROLOGY (2018)
Sweet Predictions Speak Volumes for Early Detection of Pancreatic Cancer
Kjetil Soreide
GASTROENTEROLOGY (2018)
Successful creation of pancreatic cancer organoids by means of EUS-guidedfine-needle biopsy sampling for personalized cancer treatment
Herve Tiriac et al.
GASTROINTESTINAL ENDOSCOPY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review
Anjali V. Sheahan et al.
Oncotarget (2018)
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2018)
A New Strategy to Control and Eradicate Undruggable Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Robert E. Van Sciver et al.
CANCERS (2018)
Trials and tribulations of neoadjuvant therapy in pancreatic cancer
M. Del Chiaro et al.
BRITISH JOURNAL OF SURGERY (2018)
Liquid biopsies for management of pancreatic cancer
Mohamadmahdi Samandari et al.
TRANSLATIONAL RESEARCH (2018)
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
Ujjwal Mukund Mahajan et al.
GASTROENTEROLOGY (2018)
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
Francesco Puleo et al.
GASTROENTEROLOGY (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen et al.
NATURE (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
Feifei Zhang et al.
CANCER COMMUNICATIONS (2018)
Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer
Leticia Moreira et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Emerging antibodies for the treatment of pancreatic cancer
Kalliopi Andrikou et al.
EXPERT OPINION ON EMERGING DRUGS (2017)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
Sujuan Yang et al.
CANCER BIOLOGY & THERAPY (2017)
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A. Lowery et al.
CLINICAL CANCER RESEARCH (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
D. Ansari et al.
BRITISH JOURNAL OF SURGERY (2017)
Pancreatic Cancer: A Riddle Wrapped in a Mystery inside an Enigma
Erkut Borazanci et al.
CLINICAL CANCER RESEARCH (2017)
Strategies for Increasing Pancreatic Tumor Immunogenicity
Burles A. Johnson et al.
CLINICAL CANCER RESEARCH (2017)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Genetics and Genetic Testing in Pancreatic Cancer
David C. Whitcomb et al.
GASTROENTEROLOGY (2015)
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Simeon Springer et al.
GASTROENTEROLOGY (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia?
Anne Marie Lennon et al.
CANCER RESEARCH (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Roles for KRAS in Pancreatic Tumor Development and Progression
Marina Pasca di Magliano et al.
GASTROENTEROLOGY (2013)
Therapeutic Advances in Pancreatic Cancer
Andrew Scott Paulson et al.
GASTROENTEROLOGY (2013)
Pancreatic Cancer Screening
Eun Ji Shin et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007
Kjetil Soreide et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): Additional evidence for a recently proposed model of progression
WM Klein et al.
MODERN PATHOLOGY (2002)
Pancreatic intraepithelial neoplasia -: A new nomenclature and classification system for pancreatic duct lesions
RH Hruban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Share Paper
